Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion type Assertion NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_head.
- NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion wasGeneratedBy ECO_0000203 NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_provenance.
- NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion wasDerivedFrom befree-20150227 NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_provenance.
- NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion SIO_000772 23365634 NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_provenance.
- NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion evidence source_evidence_literature NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_provenance.
- NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_provenance.